Back
Novartis AG Vs. Monte Rosa Therapeutics Industry Stock Comparison
Buy
62
NVS
Novartis AG
Last Price:
103.39
Seasonality Move:
1.51%
Sell
34
GLUE
Monte Rosa Therapeutics
Last Price:
8.49
Seasonality Move:
-8.98%
Buy
62
Novartis AG (NVS)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
- The current Novartis AG [NVS] share price is $103.86. The Score for NVS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- NVS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
- The current Monte Rosa Therapeutics [GLUE] share price is $8.63. The Score for GLUE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- GLUE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVS Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $103.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVS is experiencing slight buying pressure.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $8.63
The current trend is moderately bullish and GLUE is experiencing selling pressure, which indicates risk of future bearish movement.
NVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.65 | Sell |
| Relative Strength Index (14 RSI): | 25.09 | Sell |
| Chaikin Money Flow: | 276555 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.52 - 115.88) | Sell |
| Bollinger Bands (100): | (108.61 - 116.85) | Sell |
GLUE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 58.16 | Buy |
| Chaikin Money Flow: | -662051 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.15 - 9.31) | Buy |
| Bollinger Bands (100): | (3.88 - 7.18) | Buy |
NVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 106.84 | Sell |
| 20-day SMA: | 110.67 | Sell |
| 50-day SMA: | 113.72 | Sell |
| 200-day SMA: | 106.43 | Sell |
| 8-day EMA: | 106.54 | Sell |
| 20-day EMA: | 109.48 | Sell |
| 50-day EMA: | 111.94 | Sell |
| 200-day EMA: | 108.05 | Sell |
GLUE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.27 | Sell |
| 20-day SMA: | 7.8 | Buy |
| 50-day SMA: | 6.45 | Buy |
| 200-day SMA: | 5.53 | Buy |
| 8-day EMA: | 9.03 | Sell |
| 20-day EMA: | 8.12 | Buy |
| 50-day EMA: | 6.86 | Buy |
| 200-day EMA: | 5.74 | Buy |
Novartis AG Earnings Growth & NVS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $0.72 per share.
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.44 per share, and a decrease next year of $0.60 per share.
Novartis AG Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monte Rosa Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||